n(4)-hydroxycytidine has been researched along with fosmidomycin monosodium salt in 1 studies
Studies (n(4)-hydroxycytidine) | Trials (n(4)-hydroxycytidine) | Recent Studies (post-2010) (n(4)-hydroxycytidine) | Studies (fosmidomycin monosodium salt) | Trials (fosmidomycin monosodium salt) | Recent Studies (post-2010) (fosmidomycin monosodium salt) |
---|---|---|---|---|---|
42 | 1 | 32 | 8 | 0 | 8 |
Protein | Taxonomy | n(4)-hydroxycytidine (IC50) | fosmidomycin monosodium salt (IC50) |
---|---|---|---|
1-deoxy-D-xylulose 5-phosphate reductoisomerase | Escherichia coli K-12 | 0.22 | |
1-deoxy-D-xylulose 5-phosphate reductoisomerase | Mycobacterium tuberculosis H37Rv | 0.23 | |
1-deoxy-D-xylulose 5-phosphate reductoisomerase, apicoplastic | Plasmodium falciparum 3D7 | 0.086 | |
1-deoxy-D-xylulose 5-phosphate reductoisomerase | Escherichia coli | 0.22 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Clement, B; Indorf, P; Kubitza, C; Kunze, T; Scheidig, AJ | 1 |
1 other study(ies) available for n(4)-hydroxycytidine and fosmidomycin monosodium salt
Article | Year |
---|---|
Drug Metabolism by the Mitochondrial Amidoxime Reducing Component (mARC): Rapid Assay and Identification of New Substrates.
Topics: Biological Assay; Humans; Inactivation, Metabolic; Metabolic Clearance Rate; Mitochondria; Mitochondrial Proteins; Oxidation-Reduction; Oxidoreductases; Oximes; Substrate Specificity | 2020 |